Centessa Pharmaceuticals (CNTA) Enterprise Value (2020 - 2026)
Centessa Pharmaceuticals (CNTA) reported Enterprise Value of -$276.6 million for Q1 2026, up 2.78% year-over-year from -$269.1 million in Q1 2025, and up 6.11% quarter-over-quarter from -$294.6 million in Q4 2025.
Centessa Pharmaceuticals (CNTA) Enterprise Value (2020 - 2026) Analysis & Trends
Centessa Pharmaceuticals (CNTA) has 7 years of Enterprise Value data on file, last reported at -$276.6 million in Q1 2026.
- Enterprise Value for Q1 2026 came in at -$276.6 million, up 2.78% year-over-year; the trailing twelve-month figure through Mar 2026 was -$276.6 million (up 2.78% YoY), and the FY2025 annual result was -$294.6 million, up 38.91% from the prior year.
- Enterprise Value rose to -$276.6 million in Q1 2026 per CNTA's latest filing, from -$294.6 million in the prior quarter.
- Over five years, Enterprise Value peaked at -$230.2 million in Q1 2024 and troughed at -$544.5 million in Q1 2022.
- A 5-year average of -$349.0 million and a median of -$294.8 million in 2024 frame the typical range for Enterprise Value.
- The sharpest annual moves came in 2024 and 2025: Enterprise Value tumbled 87.95% in 2024, then surged 52.51% in 2025.
- A 5-year view of Enterprise Value shows it stood at -$393.6 million in 2022, then surged by 34.83% to -$256.5 million in 2023, then plunged by 87.95% to -$482.2 million in 2024, then soared by 38.91% to -$294.6 million in 2025, then increased by 6.11% to -$276.6 million in 2026.
- Business Quant data shows CNTA's Enterprise Value at -$276.6 million in Q1 2026, -$294.6 million in Q4 2025, and -$246.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | -32.30 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -4.14 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -286.70 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -18.44 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -2.77 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -7.20 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | -7.25 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -584.73 Mn |
| 10 | Centessa Pharmaceuticals | 6.15 Bn | 6.15 Bn | - | -276.59 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -276.59 Mn |
| Dec 31, 2025 | -294.58 Mn |
| Sep 30, 2025 | -246.21 Mn |
| Jun 30, 2025 | -250.72 Mn |
| Mar 31, 2025 | -284.51 Mn |
| Dec 31, 2024 | -482.18 Mn |
| Sep 30, 2024 | -518.45 Mn |
| Jun 30, 2024 | -294.83 Mn |
| Mar 31, 2024 | -230.18 Mn |
| Dec 31, 2023 | -256.55 Mn |
| Sep 30, 2023 | -281.34 Mn |
| Jun 30, 2023 | -303.59 Mn |
| Mar 31, 2023 | -346.23 Mn |
| Dec 31, 2022 | -393.64 Mn |
| Sep 30, 2022 | -444.80 Mn |
| Jun 30, 2022 | -484.16 Mn |
| Mar 31, 2022 | -544.50 Mn |
| Dec 31, 2021 | -595.08 Mn |
| Sep 30, 2021 | -578.82 Mn |
| Jun 30, 2021 | -613.80 Mn |